Sansum Diabetes Research Institute (SDRI) has released its Annual Report for fiscal year 2022, providing a comprehensive overview of SDRI’s activities, initiatives and accomplishments throughout the year.
Highlighting the progress SDRI made in advancing its core objectives, the report notes SDRI’s achievements, programs, and continued dedication to helping individuals and communities impacted by diabetes.
In 2022, SDRI engaged 1,779 individuals in clinical research; conducted 26 clinical research trials; provided care for 105 women living with diabetes during pregnancy; and published 26 articles in respected medical journals, the report notes.
“Releasing our 2022 Annual Report is a significant milestone for SDRI,” said Ellen Goodstein, executive director. “It provides an opportunity for us to reflect on our achievements, celebrate the progress we have made, and acknowledge the ongoing challenges faced by the diabetes community.
“The report showcases our commitment to making a positive impact for individuals impacted by diabetes and driving change in diabetes research,” she said.
Key points in the report include stories of individuals whose lives have been positively impacted by the nonprofit’s programs and services; groundbreaking research conducted in 2022; contributions of partners, donors and volunteers who have played a pivotal role in supporting SDRI’s work; and a breakdown of SDRI’s financials.
SDRI’s innovative research in 2022 includes a landmark study that evaluated the efficacy of the Dexcom G7 Continuous Glucose Monitor (CGM) in pregnancy, resulting in the FDA approval of the CGM for use during pregnancy.
The institute also conducted pivotal trials for the Dexcom G7 CGM for use in patients ages two years and older; and controlled trials evaluating a culturally tailored plant-forward diet and lifestyle therapy program for the underserved Latino population.
The Annual Report also notes the collaborations and partnerships with prestigious institutions, including the establishment of a 16-member Scientific Advisory Board comprised of global experts in diabetes research.
To view SDRI’s Annual Report, visit https://www.sansum.org/annualreport2022.